Filing Details
- Accession Number:
- 0001645470-19-000036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-06 17:21:59
- Reporting Period:
- 2019-05-30
- Accepted Time:
- 2019-06-06 17:21:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-30 | 10,000 | $0.01 | 23,976,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 1,000 | $0.01 | 23,977,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 5,000 | $0.01 | 23,982,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 5,000 | $0.01 | 23,987,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 5,000 | $0.01 | 23,992,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 5,000 | $0.01 | 23,997,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 2,000 | $0.01 | 23,999,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-30 | 15,000 | $0.01 | 24,014,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 2,000 | $0.01 | 24,016,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 5,000 | $0.01 | 24,021,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 2,500 | $0.01 | 24,023,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 20,000 | $0.01 | 24,043,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 2,000 | $0.01 | 24,045,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 15,000 | $0.01 | 24,060,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-31 | 500 | $0.01 | 24,061,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 10,000 | $0.01 | 24,071,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 10,000 | $0.01 | 24,081,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 50 | $0.01 | 24,081,147 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 9,950 | $0.01 | 24,091,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 50 | $0.01 | 24,091,147 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 1,950 | $0.01 | 24,093,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 2,000 | $0.01 | 24,095,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 50 | $0.01 | 24,095,147 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-03 | 1,950 | $0.01 | 24,097,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-04 | 16,200 | $0.01 | 24,113,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-04 | 3,800 | $0.01 | 24,117,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-04 | 10,000 | $0.01 | 24,127,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-04 | 10,000 | $0.01 | 24,137,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-04 | 10,000 | $0.01 | 24,147,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-06-04 | 10,000 | $0.01 | 24,157,097 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
